RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation

Journal of Cell Science

Volumn 127, Issue 8, 2014, Pages 1699-1711

  Riuzzi, Francesca ^a   Sorci, Guglielmo ^a   Sagheddu, Roberta ^a,b   Sidoni, Angelo ^a   Alaggio, Rita ^c   Ninfo, Vito ^c   Donato, Rosario ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Embryonal rhabdomyosarcoma; MyoD; Myogenin; PAX7; Proliferation; RAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYCLIN D1; MYOD PROTEIN; MYOGENIN; TRANSCRIPTION FACTOR PAX7; MITOGEN ACTIVATED PROTEIN KINASE; MOK PROTEIN, HUMAN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; PAX7 PROTEIN, HUMAN; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; FUSION GENE; HUMAN; HUMAN CELL; IMMUNITY; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RNA INTERFERENCE; SARCOMA CELL; SIGNAL TRANSDUCTION; TRANSIENT TRANSFECTION; UPREGULATION; ANIMAL; CARCINOGENESIS; EMBRYONAL RHABDOMYOSARCOMA; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTIGENS, NEOPLASM; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOBLASTS; MYOD PROTEIN; MYOGENIN; PAX7 TRANSCRIPTION FACTOR; RHABDOMYOSARCOMA, EMBRYONAL; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84898908231     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.136259     Document Type: Article

References (47)

1. Asakura, A., Hirai, H., Kablar, B., Morita, S., Ishibashi, J., Piras, B. A., Christ, A. J., Verma, M., Vineretsky, K. A. and Rudnicki, M. A. (2007). Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc. Natl. Acad. Sci. USA 104, 16552-16557.
2. Beccafico, S., Riuzzi, F., Puglielli, C., Mancinelli, R., Fulle, S., Sorci, G. and Donato, R. (2011). Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. Age (Dordr) 33, 523-541.
3. Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M. and Nawroth, P. P. (2005). Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83, 876-886.
4. Brack, A. S., Conboy, M. J., Roy, S., Lee, M., Kuo, C. J., Keller, C. and Rando, T. A. (2007). Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317, 807-810.
5. Breitfeld, P. P. and Meyer, W. H. (2005). Rhabdomyosarcoma: new windows of opportunity. Oncologist 10, 518-527.
6. Buckingham, M. (2006). Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr. Opin. Genet. Dev. 16, 525-532.
7. Calhabeu, F., Hayashi, S., Morgan, J. E., Relaix, F. and Zammit, P. S. (2013). Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells. Oncogene 32, 651-662.
8. Chargé, S. B. and Rudnicki, M. A. (2004). Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238.
9. Charrasse, S., Comunale, F., Gilbert, E., Delattre, O. and Gauthier-Rouvière, C. (2004). Variation in cadherins and catenins expression is linked to both proliferation and transformation of Rhabdomyosarcoma. Oncogene 23, 2420-2430.
10. Crescenzi, M., Fleming, T. P., Lassar, A. B., Weintraub, H. and Aaronson, S. A. (1990). MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. USA 87, 8442-8446.
11. Guo, K., Wang, J., Andrés, V., Smith, R. C. and Walsh, K. (1995). MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15, 3823-3829.
12. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D. and Lassar, A. B. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267, 1018-1021.
13. Hettmer, S. and Wagers, A. J. (2010). Muscling in: Uncovering the origins of rhabdomyosarcoma. Nat. Med. 16, 171-173.
14. Kalea, A. Z., Schmidt, A. M. and Hudson, B. I. (2011). Alternative splicing of RAGE: roles in biology and disease. Front. Biosci. (Landmark Ed.) 16, 2756-2770.
15. Kuang, S., Chargé, S. B., Seale, P., Huh, M. and Rudnicki, M. A. (2006). Distinct roles for Pax7 and Pax3 in adult regenerative myogenesis. J. Cell Biol. 172, 103-113.
16. Lluís, F., Perdiguero, E., Nebreda, A. R. and Muñoz-Cánoves, P. (2006). Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16, 36-44.
17. Lollini, P. L., De Giovanni, C., Landuzzi, L., Nicoletti, G., Scotlandi, K. and Nanni, P. (1991). Reduced metastatic ability of in vitro differentiated human rhabdomyosarcoma cells. Invasion Metastasis 11, 116-124.
18. Lovett, F. A., Gonzalez, I., Salih, D. A., Cobb, L. J., Tripathi, G., Cosgrove, R. A., Murrell, A., Kilshaw, P. J. and Pell, J. M. (2006). Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation. J. Cell Sci. 119, 4828-4840.
19. Murmann, O. V., Niggli, F. and Schäfer, B. W. (2000). Cloning and characterization of the human PAX7 promoter. Biol. Chem. 381, 331-335.
20. Olguin, H. C. and Olwin, B. B. (2004). Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev. Biol. 275, 375-388.
21. Olguin, H. C., Yang, Z., Tapscott, S. J. and Olwin, B. B. (2007). Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination. J. Cell Biol. 177, 769-779.
22. Parham, D. M. and Ellison, D. A. (2006). Rhabdomyosarcomas in adults and children: an update. Arch. Pathol. Lab. Med. 130, 1454-1465.
23. Puri, P. L., Avantaggiati, M. L., Balsano, C., Sang, N., Graessmann, A., Giordano, A. and Levrero, M. (1997). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16, 369-383.
24. Puri, P. L., Wu, Z., Zhang, P., Wood, L. D., Bhakta, K. S., Han, J., Feramisco, J. R., Karin, M. and Wang, J. Y. J. (2000). Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev. 14, 574-584.
25. Qualman, S. J., Coffin, C. M., Newton, W. A., Hojo, H., Triche, T. J., Parham, D. M. and Crist, W. M. (1998). Intergroup Rhabdomyosarcoma Study: update for pathologists. Pediatr. Dev. Pathol. 1, 550-561.
26. Riuzzi, F., Sorci, G. and Donato, R. (2006). The amphoterin/RAGE pair modulates myoblast proliferation, apoptosis, adhesiveness, migration and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J. Biol. Chem. 281, 8242-8253.
27. Riuzzi, F., Sorci, G. and Donato,R. (2007). RAGEexpression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth. Am. J. Pathol. 171, 947-961.
28. Riuzzi, F., Sorci, G., Sagheddu, R. and Donato, R. (2012). HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK- and myogenindependent repression of Pax7 transcription. J. Cell Sci. 125, 1440-1454.
29. Rubin, B. P., Nishijo, K., Chen, H. I., Yi, X., Schuetze, D. P., Pal, R., Prajapati, S. I., Abraham, J., Arenkiel, B. R., Chen, Q. R. et al. (2011). Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 19, 177-191.
30. Saab, R., Spunt, S. L. and Skapek, S. X. (2011). Myogenesis and rhabdomyosarcoma the Jekyll and Hyde of skeletal muscle. Curr. Top. Dev. Biol. 94, 197-234.
31. Sabourin, L. A., Girgis-Gabardo, A., Seale, P., Asakura, A. and Rudnicki, M. A. (1999). Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. 144, 631-643.
32. Schmidt, A. M., Yan, S. D., Yan, S. F. and Stern, D. M. (2001). The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108, 949-955.
33. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P. and Rudnicki, M. A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786.
34. Sebire, N. J. and Malone, M. (2003). Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J. Clin. Pathol. 56, 412-416.
35. Smith, L. M., Anderson, J. R. and Coffin, C. M. (2002). Cytodifferentiation and clinical outcome after chemotherapy and radiation therapy for rhabdomyosarcoma (RMS). Med. Pediatr. Oncol. 38, 398-404.
36. Sorci, G., Riuzzi, F., Agneletti, A. L., Marchetti, C. and Donato, R. (2003). S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol. Cell. Biol. 23, 4870-4881.
37. Sorci, G., Riuzzi, F., Arcuri, C., Giambanco, I. and Donato, R. (2004). Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol. Cell. Biol. 24, 4880-4894.
38. Sorrentino, V., Pepperkok, R., Davis, R. L., Ansorge, W. and Philipson, L. (1990). Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature 345, 813-815.
39. Takaesu, G., Kang, J. S., Bae, G. U., Yi, M. J., Lee, C. M., Reddy, E. P. and Krauss, R. S. (2006). Activation of p38a/b MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. J. Cell Biol. 175, 383-388.
40. Tiffin, N., Williams, R. D., Shipley, J. and Pritchard-Jones, K. (2003). PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells. Br. J. Cancer 89, 327-332.
41. Tomescu, O., Xia, S. J., Strezlecki, D., Bennicelli, J. L., Ginsberg, J., Pawel, B. and Barr, F. G. (2004). Inducible short-term and stable long-term cell culture systems reveal that the PAX3-FKHR fusion oncoprotein regulates CXCR4, PAX3, and PAX7 expression. Lab. Invest. 84, 1060-1070.
42. Wegorzewska, M., Krauss, R. S. and Kang, J. S. (2003). Overexpression of the immunoglobulin superfamily members CDO and BOC enhances differentiation of the human rhabdomyosarcoma cell line RD. Mol. Carcinog. 37, 1-4.
43. Weintraub, H., Davis, R., Tapscott, S., Thayer, M., Krause, M., Benezra, R., Blackwell, T. K., Turner, D., Rupp, R., Hollenberg, S. et al. (1991). The myoD gene family: nodal point during specification of the muscle cell lineage. Science 251, 761-766.
44. Weintraub, M., Kalebic, T., Helman, L. J. and Bhatia, K. G. (1997). Disruption of the MyoD/p21 pathway in rhabdomyosarcoma. Sarcoma 1, 135-141.
45. Yin, H., Price, F. and Rudnicki, M. A. (2013). Satellite cells and the muscle stem cell niche. Physiol. Rev. 93, 23-67.
46. Zammit, P. S., Golding, J. P., Nagata, Y., Hudon, V., Partridge, T. A. and Beauchamp, J. R. (2004). Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J. Cell Biol. 166, 347-357.
47. Zammit, P. S., Relaix, F., Nagata, Y., Ruiz, A. P., Collins, C. A., Partridge, T. A. and Beauchamp, J. R. (2006). Pax7 and myogenic progression in skeletal muscle satellite cells. J. Cell Sci. 119, 1824-1832.